Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joris de Groot

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|January 20, 2018
Concerns about composite reference standards in diagnostic researchNandini Dendukuri, Ian Schiller, Joris de Groot, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
Heart (British Cardiac Society)|July 20, 2022
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillationBao-Oanh Nguyen, Vanessa Weberndorfer, Harry Jgm Crijns, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|January 20, 2018
Concerns about composite reference standards in diagnostic researchNandini Dendukuri, Ian Schiller, Joris de Groot, et al.
American Heart Journal|May 10, 2022
COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy"Marina Huijboom, Moniek Maarse, Errol Aarnink, et al.
Heart (British Cardiac Society)|July 20, 2022
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillationBao-Oanh Nguyen, Vanessa Weberndorfer, Harry Jgm Crijns, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 1